At Syna we cover the entire value chain to enable biosimilars to reach patients:
— Cell bank creation
— Pharma development of the finished product
— Marketing or licence agreements
It is therefore crucial to have the scientific know-how in the field provided by LeanBio, founded by Dr. Andreu Soldevila in 2014, and the experience of the Reig Jofre group in the formulation, stabilisation and pharmaceutical development of biological, injectable and lyophilised products. Reig Jofre currently has a network of 130 business partners and is present in more than 70 countries.